CATX Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. (CATX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: November 18, 2026 , by Williamson Robert F III .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Williamson Robert F III | Director | Buy | 15,000 | $0.80 | $12.0K | 68,473 | |
| Williamson Robert F III | Director | Buy | 25,000 | $0.84 | $21.0K | 53,473 | |
| Morich Frank | Director | Buy | 15,000 | $0.94 | $14.0K | 30,000 | |
| Puhlmann Markus | Chief Medical Officer | Buy | 35,000 | $0.84 | $29.6K | 178,542 | |
| Williamson Robert F III 2 fills | Director | Buy | 24,898 | $0.84 | $20.9K | 115,271 | |
| Woods Lori A | Director | Buy | 23,750 | $0.84 | $20.0K | 28,557 | |
| Morich Frank | Director | Buy | 15,000 | $1.00 | $15.0K | 15,000 | |
| Spoor Johan M. | Chief Executive Officer | Buy | 47,000 | $0.81 | $37.9K | 106,383 | |
| Puhlmann Markus | Chief Medical Officer | Buy | 6,000 | $0.83 | $5.0K | 143,542 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.